Backgrounds/Aims: Mesenchymal stem cells (MSCs) have the capacity to differentiate into hepatocytes, The purpose of this study is to investigate the MSCs' differentiation process and therapeutic potentials by comparing isolated MSCs with HGF-treated MSCs in rat's model with thiacetamide (TAA)-induced cirrhosis. Methods: Male Sprague-Dawley (SD) rats, weighing 100-150 g were used in this study. To induce liver fibrosis, recipient rats were taken with 0.04% thioacetamide (TAA) in the drinking water (400 mg TAA/L) for 8 weeks. The rats underlying liver cirrhosis were divided into 3 groups according to the transplanted materials, compared to normal saline as control (I) and isolated MSCs (II) HGF-treated MSCs. Results: Severe hepatic fibrosis and hepatocyte destruction were detected in the control group. Less hepatic cirrhosis and collagen formation, more hepatocyte regeneration and glycogen storage were detected in isolated MSCs compared to HGF-treated MSCs group, Distribution of red autofluorescence is mainly localized near the sinusoids in isolated MSCs, scattered away the sinusoids in HGF-treated MSCs group. 
INTRODUCTION
Liver cirrhosis is a long-term consequence of chronic hepatic damage. 1 Following repeated injury, the liver undergoes regeneration and fibrosis in the process of tissue remodeling. It is characterized by excessive accumulation of extracellular matrix, with the formation of scar tissue encapsulating the area of injury. 2 No effective therapy but transplantation is currently available for this disease.
Although it is effective, extensive clinical application is limited by the lack of donor organs. 1, 3, 4 Thus, it is one of the great interests to search for an effective alternative treatment for this life-threatening disease.
Mesenchymal stem cells (MSCs) are defined as highly proliferating and adherent fibroblastic cells that have the potential to differentiated specific cells such as chodrocytes, osteocytes, adipocytes, hematopoetic stromal cells. 5, 6 Recent reports have shown that the MSCs have the capacity to differentiate into hepatocytes. Therefore, In recent years, there have been numerous studies that hepatocyte growth factor (HGF) is able to maintain the survival of MSCs and accelerate these effects. [11] [12] [13] HGF has potent cytoprotective function on hepatocyte and stimulates the migration and proliferation of activated stem cell into parenchyma. 14, 15 Simultaneous implantation MSCs with HGF can improve liver regeneration, reduce the animal's mortality as well as have the potent anti-fibrotic effect in an experimental study. 16 Some studies suggest that simultaneous implantation MSCs with HGF may be a novel therapeutic option for the treatment of liver fibrosis. 9 However, early differentiation process of MSCs to hepatic lineage such as progenitor oval cell or matrix component cells has not been elusive yet.
Initially, it would be expected that HGF has a principle role in the differentiation process of hepatocyte and result 
METHODS

Preparation of mesenchymal stem cells
TAA-induced liver fibrosis
Male, Sprague-Dawley (SD) rats, 100-150 g, purchased from Nara-Biotech (Korea) were used. Rats were maintained in an air-conditioned house with specific pathogen-free conditions, and were subjected to a 12:12-h day- Animals were anesthetized, a 3 cm-long midline abdominal incision was made, and the abdominal cavity was 
Histological study
The animals were perfused with 300-400 ml of fixative Histological appearances in the TAA-induced cirrhotic livers. For comparing isolated MSCs group with normal saline group or HGF-treated MSC group, each specimen was stained with Sirius-red stain (Original magnification: ×10, ×20); Alleviated septal fibrosis and less collagen deposition were detected in isolated MSCs group, thickened fibrosis and more collagen deposition in normal saline or HGF-treated MSCs group.
Statistical analysis
staining was reduced and depicted a strongly time-dependent lack of glycogen (Fig. 2) . Isolated MSCs group demonstrated a diffuse and homogeneous pattern of PAS staining for glycogen (Fig. 2) . Less hepatic fibrosis, more glycogen storage was detected in isolated stem cell group, compared to HGF-treated stem cell group (Fig. 2) .
Fig. 4.
Western blot analysis and RT-PCR study also showed these serial changes of fibrosis, Quantification of fibrosis induction and MSC-associated effects were assessed through antibody studies for collagen α-1 and fibronectin and RT-PCR for collagnen α-1 messanger ribonucleic andi (mRNA). The expressed amount of collagen α-1 and fibronectin were increased in 8 weeks after TAA ingestion and more decreased in additional 2 weeks after MSC infusion, contrary to control group.
Histopathologic analysis with Sirius-red staining demonstrated almost normalization of liver architecture in isolated MSCs group within 10 weeks of MSCs administration (Fig. 3) . Alleviated septal fibrosis and less collagen deposition were detected in isolated MSCs group, thickened fibrosis and more collagen deposition in normal saline or HGF-mediated MSC group. The difference between HGF-treated MSC group and control group was not prominent unexpectedly (Fig. 3) .
To assess the degree of hepatic fibrosis, expressed amount of collagen α-1 and fibronectin were measured using Western blot analysis and RT-PCR study. During thioacetamide ingestion, there was a time-dependent increase in expressed amount of collagen α-1 and fibronectin. After MSC implantation, however, a expressed amount of collagen and fibronection in fibrotic areas was decreased from week 1 to week 3. In contrast, expressed amount of collagen and fibronection in saline-injected rats increased still. Western blot analysis and RT-PCR study for collagen α-1 also supported these serial changes of fibrosis (Fig. 4) .
The change and migration of stem cell after HGF-treatment Protein expression of CK18, CD90 and β-actin in the cells was analyzed through western blot analysis (Fig. 6 ).
The protein bands for specific hepatic markers (CK-18)
were visible in HGF-treated MSCs. The protein bands of specific stem cell marker (CD 90) were visible in Isolated
MSCs. β-SMA is common in both group. Western blot analysis indicated that these specific markers were actively synthesized before and after hepatic differentiation.
HGF-treated MSCs became the CK18-positive and Isolated
MSCs CD90-postive (Fig. 6 ).
To identify Transplanted donor cell distribution to the recipient liver. We demonstrated CELL STALKER-CSR dye staining and the expression of albumin by high resolution fluorescent microscopy at 1 and 3 weeks after injection. Red autofluorescence is mainly localized near the sinusoids in stem cell group and scattered away the sinusoids in HGF-treated stem cells group, which indicate the migration of stem cells during the differentiation process (Fig. 7) .
Comparing the serial differentiation phase between Isolated MSCs and HGF-treated MSCs
Hepatogenic differentiation of implanted MSCs was determined by immunohistochemistry using antibodies to albumin and CK19. Using CELL STALKER-CSR dye to detect MSCs, we found that these cells co-localized with ities to increase the appotosis of hepatic stellate cells and restore the hepatic fibrosis compared with HGF-treated MSCs (Fig. 10 ).
DISCUSSION
The end-stage of liver disease, such as hepatic failure, end-stage cirrhosis and infections present a major health concerns. Given the shortage of organs for liver transplantation, an increasing emphasis is being placed on cell-based liver therapies. Some of these therapeutic approaches have been moderate or short-term success. 17, 18 But, hepatocyte transplantation has not evolved as a viable alternative to liver transplantation, due to difficulty in a large amount of high-quality hepatocyte collection from the same donor liver. In addition, the in vitro culture of hepatocytes for transplantation is demanding and inefficient. 19 Stem cells are therefore considered to be a potential al- In this study, after rats were treated with oral administration of TAA for 8 weeks, the liver exhibited a marked increase in extracellular matrix content and displayed bundles of collagen surrounding the lobules leading to large fibrous septa. But In 2 week later after implantation of MSCs, Less hepatic fibrosis and more hepatocyte regeneration were detected in isolated stem cell group compared to normal saline or HGF-mediated MSC group (Fig.   1C ). Histopathologic analysis demonstrated almost normalization of liver architecture in isolated MSCs group within 10 weeks of MSCs administration (Fig. 3C) . Alleviated septal fibrosis and less collagen deposition were detected in isolated MSCs group, thickened fibrosis and more collagen deposition in normal saline or HGF-mediated MSC group. The difference between HGF-treated 
